Literature DB >> 12799047

A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity.

S C G Brezinsky1, G G Chiang, A Szilvasi, S Mohan, R I Shapiro, A MacLean, W Sisk, G Thill.   

Abstract

To establish a simple and rapid method for the screening of stable recombinant Chinese hamster ovary (CHO) cell lines, we have developed a cell surface labeling technique using fluorescently tagged antibodies that bind to secreted target proteins at low temperature. Using fluorescence intensity as the sole criterion for selection of cells, we are able to enrich populations of highly productive cells using preparative flow cytometry sorting. Reiterative sorting based on selection of cells having the highest fluorescence intensity of cell surface labeled protein results in dramatic increases in specific cellular productivity. Using lymphotoxin-beta receptor IgG fusion protein as a model system, we have demonstrated a greater than 20-fold increase in specific productivity (0.49-11.5 pg cell(-1) day(-1)) (pcd) without the use of methotrexate (MTX)-mediated selection or amplification. In addition, the flow cytometry used to enrich for and clone high producer cell lines has reduced development time by more than 50% and the number of screening assays by more than 10-fold. When a transfected population of CHO cells expressing a humanized version of the murine monoclonal antibody (mAb) AQC2 directed against human alpha 1 beta 1 integrin was subjected to the same treatment, a 25-fold improvement in specific productivity (0.3-8.0 pcd) was observed. Furthermore, similar application of this technique to MTX-amplified clones resulted in up to 120-fold overall improvement in specific productivity (up to 42 pcd). Greater than 20 examples are also presented to demonstrate the robustness and performance of this technique.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799047     DOI: 10.1016/s0022-1759(03)00108-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  34 in total

1.  A high-throughput automated platform for the development of manufacturing cell lines for protein therapeutics.

Authors:  Shuangping Shi; Russ G G Condon; Liang Deng; Jason Saunders; Finn Hung; Yung-Shyeng Tsao; Zhong Liu
Journal:  J Vis Exp       Date:  2011-09-22       Impact factor: 1.355

2.  Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activity.

Authors:  Jianying Dong; Arlene Sereno; William B Snyder; Brian R Miller; Susan Tamraz; Adam Doern; Michael Favis; Xiufeng Wu; Hon Tran; Emma Langley; Ingrid Joseph; Antonio Boccia; Rebecca Kelly; Kathleen Wortham; Qin Wang; Lisa Berquist; Flora Huang; Sharon X Gao; Ying Zhang; Alexey Lugovskoy; Shelly Martin; Heather Gouvis; Steven Berkowitz; Gisela Chiang; Mitchell Reff; Scott M Glaser; Kandasamy Hariharan; Stephen J Demarest
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

3.  Transcriptome and proteome profiling to understanding the biology of high productivity CHO cells.

Authors:  Peter Morin Nissom; Arleen Sanny; Yee Jiun Kok; Yeo Thong Hiang; Song Hui Chuah; Tan Kher Shing; Yih Yean Lee; Kathy Tin Kam Wong; Wei-Shou Hu; Miranda Yap Gek Sim; Robin Philp
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

4.  In vitro immunization of Epstein-Barr virus-immortalized B cells augments antigen-specific antibody production.

Authors:  Gakuro Harada; Shin-Ei Matsumoto; Makiko Yamashita; Kaoru Fujii; Sanetaka Shirahata; Yoshinori Katakura
Journal:  Cytotechnology       Date:  2013-08-15       Impact factor: 2.058

5.  Mitochondrial aconitase is a key regulator of energy production for growth and protein expression in Chinese hamster ovary cells.

Authors:  Neha Dhami; Drupad K Trivedi; Royston Goodacre; David Mainwaring; David P Humphreys
Journal:  Metabolomics       Date:  2018-10-01       Impact factor: 4.290

Review 6.  Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.

Authors:  Scott A Smith; James E Crowe
Journal:  Microbiol Spectr       Date:  2015-02

7.  STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy.

Authors:  Lekh N Dahal; Lang Dou; Khiyam Hussain; Rena Liu; Alexander Earley; Kerry L Cox; Salome Murinello; Ian Tracy; Francesco Forconi; Andrew J Steele; Patrick J Duriez; Diego Gomez-Nicola; Jessica L Teeling; Martin J Glennie; Mark S Cragg; Stephen A Beers
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

Review 8.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

Review 9.  Better and faster: improvements and optimization for mammalian recombinant protein production.

Authors:  Steven C Almo; James D Love
Journal:  Curr Opin Struct Biol       Date:  2014-04-12       Impact factor: 6.809

10.  Intraclonal protein expression heterogeneity in recombinant CHO cells.

Authors:  Warren Pilbrough; Trent P Munro; Peter Gray
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.